Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.3.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.620NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XDMNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
LV.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HK.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GE.1.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
V.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.149NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.413NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.107NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.10 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.47NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.41 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.71NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AS.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.142NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.166NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.11 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.34.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.50NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.60NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.52NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
W.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.250NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.63NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.130NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.44NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.469NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.59NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BR.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.5.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBDNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EB.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CN.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used